We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hamburg Responds to Mounting Criticism Over FDA’s Expedited Drug Approvals
Hamburg Responds to Mounting Criticism Over FDA’s Expedited Drug Approvals
FDA Commissioner Margaret Hamburg took the unusual step Thursday of publicly defending the agency’s expedited drug approval pathways in the face of growing criticisms, which now include a congressional inquiry into the FDA’s approval standards.